Prediction of Late Breast Cancer-Specific Mortality in Recurrence-Free Breast Cancer Survivors Treated for Five Years with Tamoxifen.
Soo Yeon BaekJi Yeong KwonYoung Joo LeeSung-Chan GwarkSae Byul LeeNamshin KimIl-Young ChungBeom Seok KoHee Jeong KimSung-Bae KimSeung Do AhnGyungyub GongByung Ho SonSei-Hyun AhnJong Won LeePublished in: Journal of breast cancer (2019)
This new risk stratification system for late mortality in breast cancer can be used to identify the right candidates for extended endocrine therapy after 5 years of tamoxifen treatment.